HYFT
ImmunoPrecise Antibodies Ltd.
1.40$
-4.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 114.0% | 53.6% | 75.6% | 38.0% | 92.1% | 59.5% | 42.6% | 52.5% | 45.4% | 48.4% | 41.8% | 78.4% | 49.3% | 21.3% | 44.9% | 53.1% | 36.0% | 41.3% | 21.1% | 43.1% | 45.4% | 45.5% | 46.3% | 36.7% | 47.1% | 46.4% | 40.6% | 50.9% | 52.0% | 48.6% | 51.9% | 59.2% | 48.9% | 46.4% | 36.1% | 51.7% | 35.5% | 40.7% | 39.4% | 41.4% | 39.2% | |
| -37.1% | 46.4% | 24.4% | 100.0% | 7.9% | 40.5% | 57.4% | 47.5% | 54.6% | 51.6% | 58.2% | 21.6% | 50.7% | 78.7% | 55.1% | 46.9% | 64.0% | 58.7% | 78.9% | 56.9% | 54.6% | 54.5% | 53.7% | 63.3% | 52.9% | 53.6% | 59.4% | 49.1% | 48.0% | 51.4% | 48.1% | 40.8% | 51.1% | 53.6% | 63.9% | 48.3% | 64.5% | 59.3% | 60.6% | 58.6% | 60.8% | |
| 8.1% | – | 14.3% | 66.3% | 18.0% | 9.0% | 3.8% | 21.3% | 1.1% | 0.7% | 2.2% | 7.1% | 6.2% | 14.1% | 1.3% | 5.3% | 8.2% | 22.1% | – | 12.6% | 24.4% | 64.5% | 42.7% | 17.3% | 131.9% | 96.5% | 8.9% | 16.6% | 13.6% | 16.1% | 14.4% | 60.2% | 37.6% | 17.2% | 15.6% | 33.2% | 29.7% | 29.2% | 38.2% | 33.5% | 32.6% | |
| 50.4% | 29.6% | 133.3% | 176.1% | 109.6% | 86.1% | 106.4% | 96.0% | 67.9% | 68.8% | 62.7% | 68.9% | 68.1% | 66.8% | 25.1% | 64.7% | 52.2% | 55.6% | 80.8% | 88.4% | 84.1% | 66.5% | 73.1% | 108.6% | 90.3% | 73.9% | 118.5% | 70.1% | 53.8% | 67.2% | 63.8% | 135.6% | 106.5% | 58.4% | 53.1% | 104.2% | 74.5% | 120.4% | 128.8% | 182.1% | 125.7% | |
| 76.0% | 31.3% | 139.5% | 283.1% | 153.0% | 106.4% | 120.0% | 152.4% | 84.9% | 93.2% | 89.1% | 151.1% | 104.8% | 110.1% | 60.0% | 80.4% | 66.5% | 72.5% | 100.0% | 107.6% | 128.2% | 153.4% | 142.4% | 142.6% | 261.9% | 204.3% | 167.1% | 49.1% | 82.3% | 105.1% | 102.6% | 232.3% | 202.4% | 107.1% | 84.8% | 179.7% | 131.5% | 147.6% | 165.8% | 218.4% | 165.2% | |
| 24.0% | 15.1% | -115.1% | -183.1% | -145.1% | -65.9% | -62.6% | -104.9% | -30.3% | -41.6% | -30.9% | -129.5% | -54.1% | -31.4% | -4.9% | -33.5% | -2.5% | -13.9% | -21.1% | -50.6% | -73.6% | -98.9% | -88.7% | -79.3% | -209.0% | -150.7% | -107.6% | -80.1% | -34.3% | -53.7% | -54.4% | -191.5% | -151.3% | -53.5% | -20.9% | -131.4% | -67.0% | -88.4% | -105.2% | -159.9% | -104.4% | |
| 0.4% | 0.6% | 0.5% | 1.0% | 0.5% | 0.4% | 0.2% | 4.1% | 8.4% | 8.9% | 5.8% | 7.7% | 7.9% | 5.8% | 3.3% | 4.2% | 5.2% | 3.7% | 2.7% | 2.9% | 2.3% | 2.1% | 2.4% | 1.9% | 1.0% | – | 0.5% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | – | 0.0% | 0.0% | 0.0% | – | – | |
| 23.7% | 14.7% | -868.6% | -221.7% | -145.1% | -68.6% | -70.3% | -115.4% | -37.1% | -49.1% | -41.9% | -154.7% | -74.2% | -41.3% | -12.1% | -35.8% | -9.8% | -8.6% | -26.7% | -82.3% | -66.3% | -102.1% | -75.1% | -83.4% | -208.7% | -144.2% | -104.9% | -67.4% | -42.1% | -55.6% | -291.4% | -197.3% | -159.7% | -398.9% | -27.2% | -132.2% | -77.4% | -94.9% | -102.8% | -154.6% | -106.8% | |
| 3.2% | 2.0% | 0.9% | -20.4% | 0.5% | – | – | 6.1% | 1.3% | 5.6% | 2.2% | -9.2% | -0.1% | 1.8% | 3.4% | -13.0% | 4.8% | 1.1% | 2.0% | 20.9% | 4.1% | 4.0% | 4.3% | 5.2% | -8.6% | -2.4% | -13.6% | -7.3% | -3.0% | -12.5% | -12.0% | -26.9% | -27.3% | -49.0% | 3.7% | -2.9% | 0.6% | -0.4% | -8.9% | 4.1% | -1.2% | |
| 20.5% | 12.7% | -868.6% | -201.3% | -145.1% | -68.6% | -70.3% | -121.4% | -38.4% | -54.7% | -44.0% | -145.5% | -74.1% | -43.1% | -15.5% | -22.8% | -14.6% | -9.8% | -28.7% | -103.2% | -70.4% | -106.1% | -79.5% | -88.6% | -200.1% | -141.8% | -91.2% | -60.1% | -39.2% | -43.1% | -279.4% | -161.7% | -95.3% | -349.9% | -31.0% | -93.6% | -77.5% | -94.5% | -93.9% | -158.7% | -105.5% | |
| 25.2% | 16.0% | -865.6% | -217.0% | -138.3% | -60.8% | -64.5% | -89.4% | -17.0% | -27.6% | -22.7% | -82.5% | -23.6% | -7.3% | 13.5% | 3.3% | 20.8% | 17.0% | -2.2% | -60.3% | -43.2% | -81.8% | -55.0% | -63.9% | -175.5% | -116.0% | -69.1% | -39.9% | -12.3% | -34.4% | -266.9% | -140.7% | -102.4% | -373.4% | -14.2% | -102.4% | -72.4% | -89.7% | -99.4% | -152.9% | -103.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.